Objective: Estimating calibration performance of clinical prediction rules (CPRs) in systematic reviews of validation studies is not possible when predicted values are neither published nor accessible or sufficient or no individual participant or patient data are available. Our aims were to describe a simplified approach for outcomes prediction and calibration assessment and evaluate its functionality and validity. Study design and methods: Methodological study of systematic reviews of validation studies of CPRs: a) ABCD 2 rule for prediction of 7 day stroke; and b) CRB-65 rule for prediction of 30 day mortality. Predicted outcomes in a sample validation study were computed by CPR distribution patterns ("derivation model"). As confirmation, a logistic regression model (with derivation study coefficients) was applied to CPR-based dummy variables in the validation study. Meta-analysis of validation studies provided pooled estimates of "predicted:observed" risk ratios (RRs), 95% confidence intervals (CIs), and indexes of heterogeneity (I 2 ) on forest plots (fixed and random effects models), with and without adjustment of intercepts. The above approach was also applied to the CRB-65 rule. Results: Our simplified method, applied to ABCD 2 rule in three risk strata (low, 0-3; intermediate, 4-5; high, 6-7 points), indicated that predictions are identical to those computed by univariate, CPR-based logistic regression model. Discrimination was good (c-statistics =0.61-0.82), however, calibration in some studies was low. In such cases with miscalibration, the underprediction (RRs =0.73-0.91, 95% CIs 0.41-1.48) could be further corrected by intercept adjustment to account for incidence differences. An improvement of both heterogeneities and P-values (Hosmer-Lemeshow goodness-of-fit test) was observed. Better calibration and improved pooled RRs (0.90-1.06), with narrower 95% CIs (0.57-1.41) were achieved. Conclusion: Our results have an immediate clinical implication in situations when predicted outcomes in CPR validation studies are lacking or deficient by describing how such predictions can be obtained by everyone using the derivation study alone, without any need for highly specialized knowledge or sophisticated statistics.
Background

What is new?
A new, simplified method for computation of predicted number of outcomes in validation studies of clinical prediction rules (CPRs), for assessment of calibration performance in systematic reviews, is described. Our approach employs the frequency distribution pattern of the outcome in the derivation study (so called "derivation model"). Two CPRs (ABCD 2 and CRB-65) are used as examples. 1 
Phases of CPRs, derivation, and validation
Three obligatory phases exist in CPR development before it can be implemented in clinical practice: derivation, validation (narrow and broad), and clinical impact analysis ( Figure A1 .1 in the Supplementary materials). 2, 3 While the narrow validation can be either internal or external in the view of the derivation sample, the broad validation can be only an external one. Certain methodological standards are followed for CPR development and validation. 4 At present, most CPRs are at the stage of initial development (derivation, mainly), fewer are validated and even less still were subject to impact analysis.
The derivation of CPRs is usually based on multivariable regression modeling by assessing a continuous outcome or the presence/absence of the target disorder and enabling the CPR development according to different sources of diagnostic or prognostic information. 5 The resulting model may stratify patients into subgroups (low, intermediate or high risk) or compute predicted probabilities for the outcome. These probabilities serve to estimate, using a cut-off, the presence or absence of the outcome. CPRs can be based on and/or presented as equations with exact regression coefficients or as a more user-friendly, linear format like a simple score. 6, 7 Ideally, CPRs should be based on a small number of variables -in practice, few variables with strong effects usually explain most of the variance and account for most of the prognostic power. Although some loss of prognostic power is inevitable, the simplified rules often perform equally well compared to the more complex models. Once the CPR is derived, its overall performance (discrimination, calibration) is assessed. A reason for good performance might be that a simple rule, with a small number of highly predictive variables, is much less likely to be over-fitted (over-optimistically estimated) than complex models including also additional but weak predictors. 8 The validation of a CPR can be done by using derivation study data (narrow internal validation), new data from the same source as the derivation study or other, similar populations (narrow external validation), but a true evaluation of predictive performance and generalizability (also called "transportability") requires an evaluation in a heterogeneous population and another clinical setting/s (broad external validation). 9, 10 The proper validation implies that a fully specified, originally existing model (both the derivation study variables and coefficients) is used to compute the probability and obtain predicted outcomes and then compare the estimates to the actual outcomes in the validation study. 11 Unfortunately, the predictive performance often decreases when a model is tested in new patients, different from those in the original model. Therefore, the CPR can be further adjusted or updated by combining the initial information (derivation study) and the new data (validation study). [12] [13] [14] Predictive performance of a CPr
The predictive performance, or accuracy and reliability of a CPR in both derivation and validation studies should always be assessed in two aspects: discrimination and calibration. 15 Clinical Epidemiology 2015:7 submit your manuscript | www.dovepress.com
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A new approach to pooled analysis of calibration of CPRs in validation studies Discrimination (accuracy) refers to the ability of CPR to correctly distinguish between presence and absence of the outcome, while calibration (reliability) is the agreement between predicted probabilities of occurrence and observed proportions of the outcome. Discrimination of binary outcomes, for instance, is evaluated by concordance (c-statistic or receiver operating characteristic [ROC] curve). Good calibration refers to a good agreement between predicted probabilities and observed frequencies, eg, overall or across different strata by various CPR levels (ie, cut-off points). It is quantified by the comparison between, or ratio of the predicted to observed outcomes, usually verified by Hosmer-Lemeshow goodness-of-fit test, however, this test has low power to identify miscalibration in small samples. 16 Other tests of calibration are also applicable when IPD from validation studies do exist, however, without real IPD we used the Hosmer-Lemeshow test on "mimicked" IPD only as an illustration of some aspects of our methodological approach, eg, a (relative) change in the model calibration after an intercept adjustment. Another approach to assess calibration when IPD are not available is a direct comparison between the outcomes distribution (frequencies) in the original derivation sample and the outcome distribution in validation samples.
The latter technique is well illustrated by the association between the prognostic features of the CRB-65 rule (levels) and the risk distribution (%) for 30 day mortality among the derivation study and a single validation study (Figure 1) . 17 There is a clearly increasing risk with the increasing CRB-65 score (from 0 to 3). Although with a lower percentage of the outcome in the highest risk (4 points), the increasing trends are quite similar in both samples, in terms of both the score distribution and outcome distribution. While with good discrimination (area under the curve [AUC] ROC = 0.79; 95% CI, 0.65-0.92), the calibration in terms of outcome frequency (%) at each of the score levels is not perfect. This one-to-one comparison indicates that CRB-65 rule tends to under-predict mortality in the validation sample as compared to the derivation one (eg, CRB-65 score of 2 points relates to mortality of 8.2% versus 11.8%, Figure 1 ).
Discrimination should be prioritized when judging a set of predictions or an overall CPR performance because if discrimination is poor, no calibration adjustment or other similar refinements of reliability can correct such weak discrimination. If discrimination is good, the CPR reliability (calibration) can be improved by adjustment, without compromising discrimination. 18 Different techniques are known to adjust a CPR for improving its predictive performance during the validation (eg, recalibration, remodeling, etc). 14 For example, the Framingham score predicting 10-year cardiovascular disease (CVD) risk has been derived in the US population. 19, 20 Although with good discrimination and well calibrated to predict CVD events in populations from the USA, Australia, and New Zealand, it overestimates (over-predicts) the absolute risk in European cohorts and its direct implementation in the latter populations requires recalibration. 20 An algorithm of CPR derivation and validation, including updating, is suggested ( Figure A1 .2 in Supplementary materials).
systematic reviews and meta-analyses of CPrs
The number of derived or validated CPRs has been increasing recently. 21 Several rules may predict the same outcome and, in parallel, a single rule may be validated in multiple populations and settings. Systematic reviews and, if appropriate, meta-analyses are the preferred tools to assess the prediction and level of evidence supporting the practical use of CPRs. 22 Meta-analysis is used to summarize, evaluate, and present overall results of CPRs' performance (pooled analysis) but most frequently in terms of discrimination 23, 24 rather than calibration. 25, 26 Pooled, symmetrical summary ROC or hierarchical summary ROC curves 27, 28 are used to assess discrimination (with a "gold standard" for observed outcomes) at a particular CPR threshold. To evaluate calibration, however, predicted number of outcomes should be published or possibly derivable from within each validation study. A good example of such calibration assessment with published or accessible predicted values (expressed as "predicted to observed ratio") was reported in 2006 25 Figure 1 An example of the comparison of prognostic features of CRB-65 rule in the view of predicting 30 day mortality from pneumonia between the derivation and a validation study.
Notes:
a All patients in the present study were 65 years or older. Therefore, there were no patients with a CRB-65 score of 0. Also, no patients had a score of 4 or higher. Reproduced with the written permission from Bont et al. 
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Dimitrov et al CVD risk (Figure A1.3) . Interestingly, when all validation studies are ordered by the increasing observed CVD risk (top to bottom), a clear pattern of changing calibration, from over-prediction to under-prediction (from right to left) emerges. 25 However, such calibration assessment cannot be done if no predicted values are published or accessible from validation studies. In principle, one possible approach in such situations is to estimate outcomes by using, for instance, the CPR as a predictor in a validation study. The predicted probabilities and the number of predicted outcomes can be computed by univariable (only CPR as predictor) or multivariable models (including also other covariates). Such computation of individual probabilities is not always an immediate procedure -it often requires high-level statistical knowledge and sophisticated software or, at least, that the model equations and coefficients are published or accessible. If the latter are available, then even simple calculations with the coefficients is sufficient to produce the predicted probabilities. The main problem, when neither predicted values are published nor enough data are available (including IPD), is that none of above techniques can be used. Therefore, another, new approach is needed to predict probabilities and outcomes for the assessment of calibration levels of CPRs in systematic reviews.
The aim of our present study was to introduce and describe a new, simple methodological approach which, using information from derivation study (eg, referred to as "derivation model") allowed a calculation of the predicted values in validation studies. It is mainly applicable when individual participant, or patient data (database, IPD) are not available from all validation studies. The approach implies exploration of "predicted:observed" ratios in the usual meta-analytic way to assess CPR calibration (on a forest plot) and is illustrated by two rules: ABCD 2 and CRB-65. 29, [30] [31] The first objective was to employ the frequency distribution (%) of the observed outcomes in the derivation study and to apply it to predict the outcomes in a sample validation study. As a second objective, we aimed at confirming the functionality of the approach by using LR model coefficients from the derivation study to the validation study data. As a third objective, we aimed at assessing the role of different outcome incidences (a priori probabilities) from different validation studies, adjusting the original model intercept 13 and examining the CPR performance and pooled estimates from the metaanalysis. Only the main ABCD 2 rule results are reported in the main text (the remaining, including those on the CRB-65 rule, are shown in the Supplementary materials only).
Methods
To develop and illustrate our new approach, we utilized data from ABCD 2 rule to predict stroke in transient ischemic attack patients and CRB-65 rule to predict mortality in pneumonia patients. With the purpose of simulating IPD sets, we selected only validation studies with available numbers of patients and outcome distribution (%) at each scoring point. Also, both CPRs were derived from LR models without complex interaction terms, 33, 34 ie, only with single predictors (variables). It means that the numerical "weights" of the components (predictors) in the CPRs were based only on fitted LR model coefficients, therefore, the patients had the same ranking in the models as in the CPRs (both related to predicted probability).
The outcome in ABCD 2 rule was "stroke at 7 days" while that for the CRB-65 rule was "30 day in-hospital mortality". 30, 31 The results, in terms of calibration, are shown as "predicted:observed" RRs with 95% CIs. The RR 1 indicates under-prediction (under-estimation) of stroke or death (observed number is greater than predicted number); RR .1 indicates overprediction (over-estimation) of the outcome (observed number is less than the predicted number) while RR =1 indicates perfect calibration between observed and predicted values. Pooled estimates were calculated by fixed and random effect models while heterogeneity across studies was quantified by the I 2 -index.
New, simplified approach to derive predicted values in a validation study
The outcome distributions in derivation 33 and validation studies of ABCD 2 rule, overall and according to three strata of stroke risk (scores 0-3, 4-5, and 6-7), are presented in Figure A1 .4 and Table A1 .1 (Supplementary materials). The distribution in the original derivation study (column 3, Table 1 ) was used as a "predictive model" to which a validation study was to be related. To calculate the predicted number of strokes in the validation cohort, 33 the proportionate risk estimate from the derivation cohort was applied according to each separate stratum of risk: low (stroke risk =1.35%), intermediate (6.51%), and high (11.30%) (column 5, Table 1 ). The number of strokes across the strata of risk in the validation cohort as predicted by ABCD 2 rule "derivation model" (column 6, Table 1 ) was then compared to the observed strokes (column 7, Table 1 ). It should be noted that our new simplified approach is applicable not only to the whole sample (range) of such CPR score, overall, but if sufficient data exist (as in the example in Figure 1 ) -also to each one of the individual levels of the scoring (point) system of such CPR.
Respectively, outcome distributions in derivation and validation studies of the CRB-65 rule are presented in 
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Predicted values from the coefficients of the regression model
The next step was to confirm our findings in terms of feasibility, functionality, and agreement with other existing approaches or models (ie, to test construct or convergent validity) by using predicted outcomes by ABCD 2 rule. 33 We constructed a univariate saturated LR prediction model and its coefficients from the derivation study data. Since we did not have the original IPD, the only technique was to assume a dichotomous outcome (binary variable for stroke at 7 days: present = Yes =1 and absent = No =0) and include the ABCD 2 rule as a single, independent predictor. The ABCD 2 score (range 0-7) is not a true continuous variable and thus we avoided an assumption of linearity by including ABCD 2 rule in the model as a set of discrete independent categorical variables, with score in the low-risk ABCD 2 stratum (0-3) as a reference category. 36 We converted the ABCD 2 variable into two dummy, related dichotomous variables (one related to intermediate risk, 4-5 score and the other to high risk, 6-7 score) and included them into multiple regression model as two single predictors from the derivation study ( Figure 2 : panel A). The same technique for dummy variables was also successfully applied to the risk-stratified data from ABCD 2 validation study 33 ( Figure 2 : panel B) to use these data to apply the "derivation study" model and its coefficients (see below). Table 1 Observed and predicted number of strokes in the validation sample using the distribution patterns of strokes in the derivation sample as a predictive model* 33 ; **stroke incidence in each risk stratum of the validation study (data from California, USA) according to the distribution patterns of stroke in the original, derivation study (as used as a predictive model); ***actual number of strokes as reported in each stratum of risk. Abbreviation: ED, emergency department. 
where a is the intercept and β INT and β HIGH are the regression coefficients of the dummy variables "intermediate risk" and "high risk", respectively. The predicted probability of stroke for each simulated individual patient can be calculated as:
We obtained the regression equation with the predictors and their coefficients as:
For instance, if a patient ABCD 2 score in the derivation study has been computed as either 0, 1, 2 or 3 points (low-risk, score 0-3), this patient would get Y=−4.29 resulting in a probability of 1.35% (95% CI 0.6-2.8) to have a stroke in 7 days. A patient ABCD 2 score of 4 or 5 points would get Y=−4.29+1.63=−2.66 resulting in 6.51% (95% CI 5.1-8.3). Similarly, a patient ABCD 2 score of 6 or 7 will get Y=−4.29+2.23=−2.06 resulting in 11.3% (95% CI 8.7-14.5).
As mentioned, we used above "derivation study" coefficients to predict probabilities and number of strokes in the validation study (ie, using dummy variables as in Figure 2: panel B). The linear estimate Y VAL in the validation study 33 (column 6, Table 2 In this way, the predicted probability of stroke at individual level P (last column, Table 2 ), ie, for each simulated patient, was computed as: Table 2 individual patient probability P for stroke in the validation sample* as computed by the logistic regression equation (intercept and coefficients) from the derivation study 
Then we added up the individual probabilities P in Table 2 (last column) to predict the number of strokes within each separate stratum of risk: low-risk 0-3 (expected =5.7), intermediate risk 4-5 (25.9 ) and high risk 6-7 (15.7). When rounded, these expected values give 6, 26 and 16 predicted strokes (last column, Table 3 ).
The same algorithm, confirming the validity of our new approach to predict 30 day mortality by CRB-65 rule, is presented in the Supplementary materials (Tables A2.2A-D) .
Meta-analysis, performance measures, and adjustment of intercept (updating) in validation studies
The predicted number of strokes and predicted:observed RRs in validation studies of ABCD 2 rule are computed and subjected to meta-analysis with fixed and randomeffects models. The results are presented as pooled estimates of RRs, together with measures of discrimination, calibration, and heterogeneity (Tables 4 and 5 and forest plots in Figures 3-5) . Updating the intercept of original LR model corrects the calibration "at large", that is, it "adjusts" the mean predicted probability for the latter to become equal to frequency of the observed outcome. Only the intercept of the original model (derivation study) is adjusted. This can be achieved by fitting LR model in validation study with the intercept a as the only free parameter and the linear estimate Y VAL as an offset variable (ie, the slope is fixed at unity). 14 The following equation illustrates the adjustment procedure:
Then, the predicted probability of stroke for each separate validation study of the ABCD 2 rule was calculated with the usual equation:
Once the probabilities with the adjusted intercepts are obtained for each simulated patient, the adjusted results from the meta-analysis with fixed effects can be presented for comparison purposes, in the same way, with the measures of performance and heterogeneity (Tables 4 and 5 and forest plots in Figures 3-5 : panel C) as described in more detail in the section "Results".
The same computations from a meta-analysis (without and with adjustment) on the estimates of 30 day mortality by CRB-65 rule in validation studies are presented only in Supplementary materials (forest plots in Figures A2.3 
Results
The main result of our current methodological work was the introduction of a new, simplified approach to compute predicted values and derive "predicted:observed" ratio of outcomes and assess calibration in validation studies of CPRs. This was achieved by using information from the derivation study (eg, referred to as "derivation model") ( Table 1) .
As the main example we used the ABCD 2 rule to predict the number of strokes and the approach was confirmed in terms of construct and congruent validities of predicted estimates. Using simulated IPD with dummy variables, we fitted a CPR-based LR model with its coefficients from the derivation study to data from sample validation study ( Figure 2 and Table 2 ). We obtained the same number of predicted outcomes (Table 3) as computed by our new, simplified approach ( Table 4 ). The identical results obtained by the new simplified approach (using a linear scale distribution from derivation sample onto the validation sample, ie, as from 0 to 7 points) and by the non-linear, more complex logistic relationship with the dummy variables to get individual predicted probabilities, is confirmation of its validity. Our current analysis included derivation and validation studies that ranged in size from 136 to 1,054 patients (ABCD 2 rule) and from 137 to 1,100 patients (CRB-65 rule) (Supplementary materials: Figure A1 .4, Table A1.1, Figure A 2 .1, Table A 2.1A). Additional information on the validation studies and further details were reported earlier. 30, 31 To further illustrate usefulness of our new approach in assessing the CPR predictive performance in terms of calibration, we obtained predicted outcomes and 
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Dimitrov et al "predicted:observed" ratios in the validation studies and subjected them to formal meta-analysis. We thoroughly assessed the discrimination and calibration in each included validation study of the ABCD 2 rule (Table 4 ) and we also illustrated with forest plots the summary estimates of calibration (pooled RRs with their 95% CIs), together with levels of heterogeneity (Figures 3-5) . Notably, beyond overall good discrimination across all included studies (c-statistics 0.608-0.819), calibration levels in some of the studies were low, with a tendency of under-estimation (under-prediction). The latter tendency can be more clearly observed when illustrated by the level of assumed risk of stroke as defined by different levels of ABCD 2 rule score (low: 0-3, intermediate: 4-5 and high: 6-7 points, Table 5 ).
The slight under-prediction (RR from 0.73 to 0.91, 95% CIs include 1.00), possibly due to increased heterogeneity (18.8%-66.1%) in some of the risk strata, could be further corrected by adjustment of the original intercept to take into account the different incidence rates (a priori probabilities). In this way our new, simplified approach was able to identify low calibration levels (eg, under-prediction) which could be further refined. While discrimination does not improve further by such intercept adjustment (Table 4) , better calibration coefficients (Table 4 , last column) and improved pooled estimates (RR 0.90-1.06, Table 5 ), with narrower 95% CIs and zero heterogeneity were achieved.
Discussion
CPRs are a valuable tool in supporting clinicians, especially in primary care, in making evidence-based decisions when relying on clinical history, physical examination, and basic investigations. We employ a pragmatic approach to introduce new, simplified methodology of computing the predicted number and "predicted:observed" ratio of outcomes in validation studies of CPRs for assessing calibration in systematic reviews.
Main results
In the context of previous research on CPR validation where preference was always given to discrimination rather than calibration, our current results indicate the usefulness, feasibility, and validity (construct and congruent) of our new approach for calibration assessment. Producing predicted outcomes and pooled estimates of calibration, based on the frequency distribution pattern (%) of the outcome in the CPR derivation study, is denoted as a "derivation model". Note: *H-L, Hosmer-Lemeshow "goodness-of-fit" P-value (a non-significant P-value means good fit -the higher the P-value, the better the fit). Abbreviation: CPr, clinical prediction rule; ED, emergency department. 
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The clinical need for assessing calibration of CPR, and possibly improving it, has been clearly shown by discrepancies in the application of the Framingham score for 10-year CVD risk in European populations. 19, 20 While being calibrated in populations from the USA, Australia, and New Zealand, it overestimates (over-predicts) the absolute risk in Europe and requires further recalibration. 20 A systematic review of validation studies even indicated that an interesting, newly detected dynamic pattern from over-prediction to underprediction emerges with the increase of the observed risk. 47 Tsivgoulis et al (2007) 49 Rothwell et al (2007) , Oxford population 47 Tsivgoulis et al (2010) 50 Song et al (2009) 48 Asimos et al (2007) 41 Fothergill et al (2009) 45 Ay et al (2009) 42 Cucchiara et al (2009) 44 Ong et al (2010) 48 Johnston et al (2007), California ED 43 Tsivgoulis et al (2010) 50 Cucchiara et al (2009) 44 Rothwell et al (2007), Oxford population 47 Tsivgoulis et al (2007) 49 Fothergill et al (2009) 45 Ong et al (2010) 46 Asimos et al (2007) 41 Ay et al (2009) 42 Rothwell Ong et al (2010) 46 Ay et al (2009) 42 Song et al (2009) 48 Rothwell et al (2007), Oxford population 47 Tsivgoulis et al (2010) 50 Fothergill et al (2009) 45 Asimos et al (2007) 41 Tsivgoulis et al (2007) 
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Dimitrov et al However, the above conjectures about calibration could never have been made if the predicted outcomes had not existed in CPR validation studies or were not accessible.
Our new approach is very useful in producing predicted outcomes by CPRs when needed for: i) assessment of calibration levels and/or subsequent inclusion of validation studies in meta-analysis; ii) signaling miscalibration and measuring improvements of calibration by updating (eg, adjustment of the intercept of derivation model); iii) comparison with predicted values as computed by other models and techniques (eg, confirmation of construct validity in ABCD 2 and CRB-65 rules); and iv) further testing and, if necessary, refinement and improvement 42 Song et al (2009) 48 Tsivgoulis et al (2007) 49 Rothwell et al (2007) , Oxford population 47 Johnston et al (2007), California ED 43 Cucchiara et al (2009) 44 Ong et al (2010) 46 Tsivgoulis et al (2010) 50 Fothergill et al (2009) 45 Asimos et al (2007) 41 Rothwell et al (2007) 44 Fothergill et al (2009) 45 Rothwell et al (2007), Oxford population 47 Tsivgoulis et al (2007) 49 Ong et al (2010) 46 Johnston et al (2007), California ED 43 Ay et al (2009) 42 Song et al (2009) 48 Asimos et al (2007) 46 Fothergill et al (2009) 45 Cucchiara et al (2009) 44 Rothwell et al (2007) , Oxford population 47 Rothwell et al (2007), Oxford clinic 47 Tsivgoulis et al (2007) 49 Tsivgoulis et al (2010) 
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A new approach to pooled analysis of calibration of CPRs in validation studies in terms of transportability with assessment and comparison of calibration between different but similar CPRs for the same outcome in same or different validation populations. To note, the same approach is also applicable to systematic reviews of validation studies for prediction of long-term risk of stroke after transient ischaemic attack. 32 
limitations
One limitation of our approach is that the pooled analysis does not consider the specific frequency of the outcomes in each separate study; however, such assessment of calibration may be seen also as a new way for preliminary analysis to quantify, beyond the discrimination, the level of CPR 44 Ong et al (2010) 46 Tsivgoulis et al (2010) 50 Fothergill et al (2009) 45 Tsivgoulis et al (2007) 49 Johnston et al (2007), California ED 43 Ay et al (2009) 42 Song et al (2009) 42 Rothwell et al (2007), Oxford clinic 47 Cucchiara et al (2009) 44 Asimos et al (2007) 41 Tsivgoulis et al (2007) 49 Johnston et al (2007), California ED 43 Ong et al (2010) 46 Fothergill et al (2009) 45 Tsivgoulis et al (2010) 50 Rothwell et al (2007) , Oxford population 47 Song et al (2009) 46 Tsivgoulis et al (2010) 50 Cucchiara et al (2009) 44 Asimos et al (2007) 41 Tsivgoulis et al (2007) 49 Rothwell et al (2007) , Oxford population 47 Johnston et al (2007), California ED 43 Song et al (2009) 48 Rothwell et al (2007), Oxford clinic 47 Ay et al (2009) 42 Fothergill et al (2009) calibration and to decide whether or not a rule should be recalibrated (eg, intercept adjustment). This is especially useful when IPD from validation studies are neither available nor easily accessible. Second, the CPR calibration might be influenced by the incidence in a separate validation study. However, before any further advice is given for recalibration, the predicted values and estimated calibration (ie, predicted versus observed values with their 95% CIs) can be adjusted to or computed for a range of different incidences. The latter approach was successfully applied in meta-analysis of validation studies of Centor score. 37 For instance, the posttest probabilities of group A beta-hemolytic streptococcal pharyngitis were computed in a tabular form for a range of pre-test (prevalence) probabilities by the Poses's method 38 using the likelihood ratio formulation of the Bayes' theorem to adjust for different prevalence rates. Last but not least, in the current approach we used each of the tested CPRs as single (solely) predictor of the outcome, however, these rules had components (signs or symptoms) with more or less the same weight (1 or 2 points each) and the underlying models had no complex interaction terms.
Clinical relevance and future research
Our results have immediate clinical application in the view of summarizing best available evidence (systematic review) from validation studies of CPRs. They allow subjecting each study's data to formal meta-analysis to produce pooled estimates not only of discrimination, but also of calibration by applying previously published models (derivation study) to a new, validation population. Unfortunately, currently only about half of the derived CPRs in primary care have been validated and only a few have been assessed for clinical impact. 39 As another recent study has also emphasized, 40 the use of appropriately validated and tested CPRs is one of the best ways of implementing evidence-based medicine for diagnosis and prognosis in the clinical practice. In this sense we suggest that all systematic reviews with meta-analysis of CPR, as well as all validation studies, always report both discrimination and calibration analyses. Finally, the potential gain in predictive accuracy and generalizability of CPR developed on combined datasets, with IPD from various studies on the same outcome (ie, IPD meta-analysis) is an area of recently intensified research that warrants further investigations.
Conclusion
In summary, our current study has presented a new, simplified method for computation of predicted number of outcomes in validation studies of CPRs for assessment of calibration performance. This method is based on the frequency distribution pattern of derivation study outcomes. We illustrated the development and application of this new approach (ie, "derivation model") on two clinically relevant and widely used CPRs (ABCD 2 and CRB-65). Our new approach was tested and further confirmed in terms of functionality and validity by original, univariate, CPR-based LR modeling (ie, with dummy variables) using derivation study data. The application of coefficients from this regression model to a sample validation study produced virtually identical predicted values of stroke across the three risk strata of ABCD 2 score (low, 0-3; intermediate, 4-5; high, 6-7 points). Then, by using our new method, we successfully computed predicted values in all included validation studies and obtained pooled estimates of "predicted:observed" RRs with their 95% CIs. Given the good discrimination performance, the slight under-prediction of strokes was further improved by intercept adjustment to show how different incidences of the outcome in each validation study can be considered and thus, providing further evidence on the usefulness of our approach. Once such miscalibration in a meta-analysis is signaled by our new approach, further refinements of the original intercept are possible by more sophisticated modeling exercises. Similarly, the successful application of our new method was also illustrated on the CRB-65 rule (Supplementary materials).
When predicted outcomes are neither published nor sufficient as from within validation studies of CPRs, or no IPD are available, our simplified approach illustrates, for the first time, how predicted outcomes can be obtained by everyone, when using only derivation study, without any further requirements for highly-specialized knowledge or sophisticated analyses. Last but not least, our new results have immediate clinical implication in contributing to exploration of the best available evidence from validation studies of CPRs (ie, systematic reviews). They allow not only subjecting the data to meta-analysis for computation of discrimination but also to produce pooled estimates for evaluation of calibration in new, validation populations.
